Characteristics of severe asthma with fungal sensitization.

[1]  D. Larenas-Linnemann,et al.  Clinical Evaluation and Management of Patients with Suspected Fungus Sensitivity. , 2016, The journal of allergy and clinical immunology. In practice.

[2]  M. Taniguchi,et al.  Serological diagnosis of allergic bronchopulmonary mycosis: Progress and challenges. , 2016, Allergology international : official journal of the Japanese Society of Allergology.

[3]  N. Rezaei,et al.  Serum IL-33 Is Elevated in Children with Asthma and Is Associated with Disease Severity , 2016, International Archives of Allergy and Immunology.

[4]  M. Taniguchi,et al.  Sensitization to fungal allergens: Resolved and unresolved issues. , 2015, Allergology international : official journal of the Japanese Society of Allergology.

[5]  A. Bush,et al.  Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33 , 2015, The Journal of allergy and clinical immunology.

[6]  Helen K. Reddel,et al.  A summary of the new GINA strategy: a roadmap to asthma control , 2015, European Respiratory Journal.

[7]  T. Betsuyaku,et al.  Phenotype of asthma related with high serum periostin levels. , 2015, Allergology international : official journal of the Japanese Society of Allergology.

[8]  J. Girard,et al.  IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. , 2014, Current opinion in immunology.

[9]  S. Akthar,et al.  Alternaria-derived serine protease activity drives IL-33–mediated asthma exacerbations , 2014, The Journal of allergy and clinical immunology.

[10]  M. Kanazawa,et al.  Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. , 2014, Respiratory investigation.

[11]  Liang Dong,et al.  IL-33 promotes airway remodeling and is a marker of asthma disease severity , 2014, The Journal of asthma : official journal of the Association for the Care of Asthma.

[12]  A. Wardlaw,et al.  Fungal allergy in asthma–state of the art and research needs , 2014, Clinical and Translational Allergy.

[13]  F. Nomura,et al.  Glucoamylase is a major allergen of Schizophyllum commune , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[15]  T. Betsuyaku,et al.  Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation , 2013, Nature Communications.

[16]  A. Bush,et al.  IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. , 2013, The Journal of allergy and clinical immunology.

[17]  Julie M. Kezik,et al.  Household mold and dust allergens: exposure, sensitization and childhood asthma morbidity. , 2012, Environmental research.

[18]  E. Bel,et al.  Current treatment of severe asthma , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  S. Wenzel.  Asthma phenotypes: the evolution from clinical to molecular approaches , 2012, Nature Medicine.

[20]  Efficacy of using the Japanese version of the asthma control test for determing the level of asthma control in clinical settings. , 2012, Allergology international : official journal of the Japanese Society of Allergology.

[21]  Nicola A Hanania,et al.  Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.

[22]  H. Kita,et al.  Human Eosinophil Innate Response to Alternaria Fungus through Protease-Activated Receptor-2 , 2011, International Archives of Allergy and Immunology.

[23]  P. Stenner,et al.  Measuring asthma‐specific quality of life: structured review , 2011, Allergy.

[24]  R. Agarwal,et al.  Severe asthma and fungi: current evidence. , 2011, Medical mycology.

[25]  S. Kato,et al.  Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias , 2010, European Respiratory Journal.

[26]  N. Goplen,et al.  Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma. , 2009, The Journal of allergy and clinical immunology.

[27]  D. Denning,et al.  The link between fungi and severe asthma: a summary of the evidence , 2006, European Respiratory Journal.

[28]  Bénédicte Leynaert,et al.  Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey , 2002, BMJ : British Medical Journal.

[29]  P. Black,et al.  Sensitivity to fungal allergens is a risk factor for life‐threatening asthma , 2000, Allergy.

[30]  V. Persky,et al.  Effect of environmental molds on risk of death from asthma during the pollen season. , 1995, The Journal of allergy and clinical immunology.

[31]  S. Leeder,et al.  Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[32]  G. Guyatt,et al.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. , 1992, Thorax.

[33]  K. Offord,et al.  Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. , 1991, The New England journal of medicine.